Zobrazeno 1 - 10
of 155
pro vyhledávání: '"David S, Burgess"'
Autor:
Justin A. Clark, David S. Burgess
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT Metallo-beta-lactamase (MBL)-producing carbapenem-resistant Enterobacteriaceae (CRE) infections continue to pose a serious threat to healthcare. Due to their unique active site, MBLs evade the activity of many novel beta-lactam/beta-lactamas
Externí odkaz:
https://doaj.org/article/f0528a401f924ba498172a73bec91198
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Abstract Objective: We sought to compare patient outcomes between carbapenem-resistant Enterobacterales (CRE) and carbapenem-susceptible Enterobacterales (CSE) infections at our academic medical center. Design: We conducted a retrospective cohort
Externí odkaz:
https://doaj.org/article/cd06fde23ed049b3a4b45ec9eb14d373
Autor:
C. Tyler Pitcock, Aric Schadler, David S. Burgess, Donna R. Burgess, Sarah E. Cotner, Jeremy Van Hoose, Eric R. Gregory, Katie L. Wallace
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Vancomycin therapy is associated with an increased risk of acute kidney injury (AKI). Previous studies suggest that area under the curve (AUC) monitoring reduces the risk of AKI, but literature is lacking to support this in patie
Externí odkaz:
https://doaj.org/article/438f7acd355d47259c9169799d8deb4c
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
We assessed breakpoint changes of 13,101 Enterobacterales and Pseudomonas aeruginosa isolates from the past decade. All β-lactams and fluoroquinolones demonstrated decreased susceptibilities following breakpoint changes. Enterobacter cloacae experie
Externí odkaz:
https://doaj.org/article/d708f42d420c47ae950f85b53eaea941
Autor:
Connor M. Anderson, Jeremy D. VanHoose, Donna R. Burgess, David S. Burgess, Aric Schadler, J. Zachary Porterfield, Katie L. Wallace
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: The objective of this study was to determine antibiotic appropriateness based on Loeb minimum criteria (LMC) in patients with and without altered mental status (AMS). Design: Retrospective, quasi-experimental study assessing po
Externí odkaz:
https://doaj.org/article/19d27f3047754755aadb3004eee5e74c
Autor:
Alexander H. Flannery, Katie L. Wallace, Christian N. Rhudy, Allison S. Olmsted, Rachel C. Minrath, Stuart M. Pope, Aaron M. Cook, David S. Burgess, Peter E. Morris
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 8 (2021)
Background: While vancomycin loading doses may facilitate earlier pharmacokinetic–pharmacodynamic target attainment, the impact of loading doses on clinical outcomes remains understudied. Critically ill patients are at highest risk of morbidity and
Externí odkaz:
https://doaj.org/article/0f0650b45efd422892e51db25aeace57
Autor:
Justin A. Clark, David S. Burgess
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 7 (2020)
Objective: To review the mechanism of action, mechanisms of resistance, in vitro activity, pharmacokinetics, pharmacodynamics, and clinical data for a novel aminoglycoside. Data sources: A PubMed search was performed from January 2006 to August 2019
Externí odkaz:
https://doaj.org/article/3a9abd99dc6943a9adbcdcb1eaccaac7
Publikováno v:
The Journal of Clinical Pharmacology. 62:479-485
β-Lactams are the most commonly used antibiotics in intensive care units (ICUs). As critically ill patients often experience pharmacokinetic aberrations, and rates of antimicrobial resistance vary between hospital settings, reliance on tertiary sour
Publikováno v:
Antibiotics, Vol 4, Iss 4, Pp 643-652 (2015)
Pseudomonas aeruginosa is a common pathogen implicated in nosocomial infections with increasing resistance to a limited arsenal of antibiotics. Monte Carlo simulation provides antimicrobial stewardship teams with an additional tool to guide empiric t
Externí odkaz:
https://doaj.org/article/d1da79816568450994cecf5a7cfa2ddb
Autor:
Katie B. Olney, Katie L. Wallace, Ryan P. Mynatt, David S. Burgess, Kaitlyn Grieves, Austin Willett, Johann Mani, Alexander H. Flannery
Publikováno v:
Pharmacotherapy
INTRODUCTION: Consensus guidelines recommend targeting a vancomycin area under the curve to minimum inhibitory concentration (AUC(24):MIC) ratio of 400-600 to improve therapeutic success and reduce nephrotoxicity. Although guidelines specify either B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64fdbfb863ef0f6a1d1f0d14b6c2b0e1
https://europepmc.org/articles/PMC9750735/
https://europepmc.org/articles/PMC9750735/